August 12, 2026
Remepy
Remepy is preparing its AI-driven Parkinson's treatment for Phase III clinical trials.
- Round
- Series A
- Amount raised
- $36M
- Lead investor
- O.G. Venture Partners
- Industry
- Biotechnology, Artificial Intelligence, Pharmaceuticals
- Headquarters
- United States
- Employees
- 11-50 employees
- Website
- remepy.com
- View profile →
Other investors
- M Ventures
Source: Google Alerts